Department of General Surgery, Digestive Disease & Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of General Anesthesiology, Transplant Center and Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.
Surgery. 2020 Jul;168(1):33-39. doi: 10.1016/j.surg.2020.02.017. Epub 2020 Apr 5.
Transjugular intrahepatic portosystemic shunt has been established as an effective treatment for complicated portal hypertension. This retrospective study investigated the effect of pretransplant transjugular intrahepatic portosystemic shunt placement on intraoperative graft hemodynamics and surgical outcomes after liver transplantation.
Of 1,081 patients who underwent liver transplantation between January 2007 and June 2017 at Cleveland Clinic (OH, USA), 130 patients had transjugular intrahepatic portosystemic shunt placement before liver transplant. We performed a 1:2 propensity score matching to compare intraoperative graft hemodynamics and surgical outcomes between the transjugular intrahepatic portosystemic shunt group (n = 130) and the no-transjugular intrahepatic portosystemic shunt group (n = 260).
The transjugular intrahepatic portosystemic shunt did not increase operative time, the volume of blood transfusion, duration of hospital stay, or complication rates. Graft and patient survivals were similar between the groups. Mean intraoperative cardiac output and graft portal flow in the transjugular intrahepatic portosystemic shunt group were greater than in the no-transjugular intrahepatic portosystemic shunt group (P = .03 and P = .003, respectively). In multivariate analysis, male sex, younger age, low platelet count, absence of portal vein thrombosis, and pretransplant transjugular intrahepatic portosystemic shunt placement were independently associated with increased portal flow volume (P < or = 0.03 each). Transjugular intrahepatic portosystemic shunt malposition was observed in 17 patients (13.1%). The 1-year patient survival was 70.6% with transjugular intrahepatic portosystemic shunt malposition and 92.0% without transjugular intrahepatic portosystemic shunt malposition (P = .01).
Our findings suggest that pretransplant transjugular intrahepatic portosystemic shunt placement increases graft portal flow but does not compromise surgical outcomes after liver transplantation. Transjugular intrahepatic portosystemic shunt malposition, however, is not uncommon and may increase the complexity of transplantation.
经颈静脉肝内门体分流术已被确立为治疗复杂门脉高压的有效方法。本回顾性研究调查了肝移植前经颈静脉肝内门体分流术对肝移植术中移植物血流动力学和手术结果的影响。
在克利夫兰诊所(美国俄亥俄州) 2007 年 1 月至 2017 年 6 月期间接受肝移植的 1081 例患者中,有 130 例患者在肝移植前进行了经颈静脉肝内门体分流术。我们进行了 1:2 的倾向评分匹配,以比较经颈静脉肝内门体分流术组(n=130)和无经颈静脉肝内门体分流术组(n=260)之间的术中移植物血流动力学和手术结果。
经颈静脉肝内门体分流术并未增加手术时间、输血量、住院时间或并发症发生率。两组患者和移植物存活率相似。经颈静脉肝内门体分流术组的术中心输出量和移植物门静脉流量均大于无经颈静脉肝内门体分流术组(P=0.03 和 P=0.003)。多变量分析显示,男性、年龄较小、血小板计数低、无门静脉血栓形成和肝移植前经颈静脉肝内门体分流术与门静脉流量增加独立相关(P≤0.03 各)。17 例(13.1%)患者出现经颈静脉肝内门体分流术位置不当。经颈静脉肝内门体分流术位置不当的患者 1 年生存率为 70.6%,无经颈静脉肝内门体分流术位置不当的患者为 92.0%(P=0.01)。
我们的研究结果表明,肝移植前经颈静脉肝内门体分流术可增加移植物门静脉流量,但不影响肝移植后的手术结果。然而,经颈静脉肝内门体分流术位置不当并不少见,可能会增加移植的复杂性。